CN Stock MarketDetailed Quotes

688526 Wuhan Keqian Biology Co.,Ltd

Watchlist
  • 18.17
  • +0.38+2.14%
Market Closed Apr 30 15:00 CST
8.47BMarket Cap24.36P/E (TTM)

Wuhan Keqian Biology Co.,Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
10.24%800.29M
27.56%581.74M
49.61%692.16M
-31.79%418.82M
32.74%725.98M
-17.88%456.07M
-77.13%462.63M
-67.69%614M
-74.30%546.91M
-70.98%555.36M
Transactional financial assets
13.03%695.12M
10.40%745.04M
69.15%910.04M
188.48%793.04M
153.12%614.96M
216.90%674.83M
156.20%538.01M
30.91%274.9M
51.84%242.95M
-21.13%212.95M
Notes receivable and accounts receivable
-24.10%312.35M
-18.45%331.41M
-5.23%395.76M
16.90%414.46M
46.90%411.54M
47.62%406.38M
85.23%417.61M
86.60%354.54M
23.67%280.14M
48.88%275.29M
-Notes receivable
----
----
----
-58.43%43.37M
448.59%70.31M
1,005.53%82.67M
211.88%105.47M
1,400.67%104.32M
-18.38%12.82M
-76.64%7.48M
-Accounts receivable
-8.46%312.35M
2.38%331.41M
26.79%395.76M
48.31%371.1M
27.64%341.23M
20.87%323.71M
62.88%312.14M
36.70%250.22M
26.80%267.33M
75.17%267.81M
Other receivables (including interest and dividends)
-6.99%3.89M
42.19%3.73M
52.92%3.41M
-17.28%4.18M
-5.31%4.18M
1.50%2.62M
-33.01%2.23M
46.92%5.05M
74.61%4.42M
16.57%2.58M
-Other receivable
----
42.19%3.73M
----
-17.28%4.18M
----
1.50%2.62M
----
46.92%5.05M
----
16.57%2.58M
Advance payment
-65.83%3.69M
-15.72%7.69M
-43.36%6.99M
5.68%10M
2.18%10.8M
-11.30%9.12M
-69.20%12.35M
-59.67%9.46M
-59.22%10.57M
-47.12%10.29M
Inventories
-15.70%146.44M
-14.52%144.8M
17.09%156.31M
35.99%163.4M
47.86%173.71M
55.68%169.4M
16.02%133.49M
14.12%120.16M
26.85%117.49M
53.12%108.82M
Receivable financing
-100.00%10
8,256.80%11.74M
----
----
-82.23%2.84M
-99.27%140.44K
--2M
--2.02M
--15.96M
--19.11M
Non-current assets due within one year
-42.74%484.15M
-44.35%468.74M
162.06%808.71M
1,256.01%990.17M
47.32%845.47M
46.04%842.33M
--308.59M
--73.02M
--573.9M
--576.78M
Other current assets
--26.85M
--271.2M
----
----
----
----
----
----
----
--129.84K
Total current assets
-11.35%2.47B
0.20%2.57B
58.42%2.97B
92.28%2.79B
55.63%2.79B
45.40%2.56B
-28.30%1.88B
-40.26%1.45B
-31.99%1.79B
-28.45%1.76B
Non Current assets
Other equity investment
49,846.86%99.89M
48,185.89%96.57M
33.33%200K
33.33%200K
33.33%200K
33.33%200K
0.00%150K
50.00%150K
50.00%150K
50.00%150K
Fixed assets
----
-9.27%799.01M
----
8.10%839.29M
----
70.85%880.59M
----
48.49%776.4M
----
152.95%515.43M
Constru in process
----
153.25%43.05M
----
-93.89%9.41M
----
-95.63%17M
----
-25.25%154.14M
----
9.79%388.72M
Productive biological assets
--8.77M
--10.05M
--8.99M
----
----
----
----
----
----
----
Intangible assets
-0.76%58.52M
0.19%60.03M
4.16%58.87M
0.96%58.03M
2.64%58.97M
4.67%59.91M
0.18%56.52M
3.06%57.47M
8.77%57.45M
7.16%57.24M
Goodwill
0.00%3.31M
0.00%3.31M
0.00%3.31M
0.00%3.31M
--3.31M
--3.31M
--3.31M
--3.31M
----
----
Long deferred expense
--1.11M
--1.18M
----
----
----
----
----
----
----
----
Deferred tax assets
-98.25%505.2K
-98.88%299.89K
51.21%34.86M
64.13%31.87M
61.16%28.9M
64.69%26.8M
15.98%23.06M
18.65%19.42M
39.03%17.94M
42.06%16.28M
Usufruct assets
-11.91%6.61M
-12.82%6.79M
6.20%6.92M
7.30%7.21M
--7.5M
--7.79M
--6.51M
--6.72M
----
----
Other non current assets
24.95%1.14B
30.06%1.08B
-33.97%811.77M
-43.51%788.13M
-12.86%910.66M
-15.42%834.13M
1,867.06%1.23B
1,403.47%1.4B
904.86%1.05B
3,619.43%986.2M
Total non current assets
13.96%2.15B
15.05%2.11B
-21.07%1.76B
-27.99%1.74B
-6.90%1.88B
-6.84%1.83B
118.19%2.24B
169.84%2.41B
179.11%2.02B
202.47%1.96B
Total assets
-1.15%4.62B
6.39%4.67B
15.21%4.74B
17.22%4.53B
22.48%4.67B
17.86%4.39B
12.90%4.11B
16.21%3.87B
13.54%3.81B
19.75%3.73B
Liabilities
Current liabilities
Short term loan
-37.52%155.08M
57.02%206.65M
225.67%228.16M
693.18%238.15M
2,378.61%248.19M
629.98%131.6M
45.74%70.06M
-25.02%30.03M
-66.66%10.01M
-69.98%18.03M
Notes payable and accounts payable
-45.80%120.83M
-32.44%165.03M
-29.47%180.04M
-22.58%188.58M
1.15%222.92M
13.22%244.27M
13.44%255.27M
49.09%243.59M
107.73%220.38M
48.28%215.74M
-Notes payable
-59.83%17.06M
-31.88%32.69M
17.03%40.24M
-45.05%22.01M
85.22%42.47M
142.93%47.99M
89.88%34.39M
653.76%40.05M
52.47%22.93M
--19.76M
-Accounts payable
-42.50%103.76M
-32.58%132.34M
-36.71%139.79M
-18.16%166.57M
-8.61%180.44M
0.15%196.27M
6.75%220.89M
28.76%203.54M
116.86%197.45M
34.71%195.99M
Contract liabilities
5.24%203.85M
54.97%157.61M
31.96%207.22M
63.25%137.02M
37.85%193.69M
60.96%101.7M
-21.95%157.03M
-23.52%83.93M
-32.67%140.51M
-1.23%63.18M
Salaries payable
-18.24%20.59M
0.33%49.57M
29.10%43.9M
10.68%32.44M
53.28%25.18M
0.73%49.41M
-26.00%34M
-28.49%29.31M
-41.64%16.43M
28.30%49.05M
Taxs payable
184.43%63.18M
57.14%57.82M
88.56%46.71M
346.79%28.48M
14.24%22.21M
-31.64%36.79M
-43.78%24.77M
-43.99%6.38M
-42.97%19.44M
98.87%53.82M
Other payable (including interest and dividends)
-24.36%40.3M
-32.67%39.64M
41.06%55.62M
30.96%48.84M
93.65%53.28M
87.46%58.87M
69.69%39.43M
118.50%37.29M
27.35%27.51M
67.07%31.4M
-Other payable
----
-32.67%39.64M
----
30.96%48.84M
----
87.46%58.87M
----
118.50%37.29M
----
67.07%31.4M
Non current liabilities due within one year
2,996.75%31.18M
12,416.81%81.11M
39,602.61%81.08M
81,425.93%51.04M
-97.49%1.01M
-98.92%648.04K
--204.21K
--62.61K
--40.04M
--60.06M
Other current liabilities
-24.27%2.31M
49.10%831.75K
-94.79%2.99M
-99.27%728.85K
-22.99%3.06M
-41.78%557.84K
1,511.82%57.33M
6,690.55%100.47M
-15.91%3.97M
67.68%958.19K
Total current liabilities
-17.18%637.31M
21.55%758.25M
32.53%845.71M
36.57%725.28M
60.89%769.54M
26.73%623.84M
7.95%638.11M
38.26%531.06M
10.36%478.3M
38.98%492.24M
Current liabilities
Estimate liabilities
----
----
----
0.00%1.99M
0.00%1.99M
0.00%1.99M
-29.28%1.99M
-29.28%1.99M
-29.28%1.99M
-29.28%1.99M
Deferred tax liabilities
-74.23%15.01M
-77.18%12.97M
20.27%58M
46.61%59.53M
76.46%58.25M
91.55%56.84M
435.82%48.22M
28.63%40.6M
242.69%33.01M
241.31%29.68M
Long term deferred income
-7.32%56.71M
-8.26%56.62M
13.75%60M
7.54%58.8M
8.07%61.19M
29.94%61.72M
11.08%52.74M
12.95%54.68M
55.04%56.62M
29.37%47.5M
Lease liabilities
-15.44%5.67M
-19.32%5.75M
-2.71%6.43M
-2.28%6.5M
--6.71M
--7.12M
--6.61M
--6.65M
----
----
Total non current liabilities
-71.15%77.4M
-71.87%75.34M
13.56%124.42M
50.90%156.82M
192.78%268.25M
238.25%267.79M
22.70%109.57M
25.53%103.92M
87.11%91.62M
64.16%79.17M
Total liabilities
-31.13%714.71M
-6.51%833.59M
29.75%970.13M
38.92%882.11M
82.09%1.04B
56.04%891.63M
9.89%747.68M
36.01%634.98M
18.16%569.93M
42.00%571.41M
Shareholders equity
Paid-in capital
-0.01%466.17M
-0.01%466.17M
0.12%466.17M
0.23%466.21M
0.23%466.21M
0.23%466.21M
0.10%465.59M
0.03%465.13M
0.03%465.13M
0.03%465.13M
Capital reserve funds
0.48%1.14B
0.48%1.14B
0.65%1.13B
1.45%1.14B
1.84%1.14B
1.84%1.14B
1.96%1.13B
1.37%1.12B
0.98%1.11B
0.98%1.11B
Surplus reserve funds
0.00%269.37M
0.00%269.37M
17.82%269.37M
17.82%269.37M
17.82%269.37M
17.82%269.37M
33.14%228.63M
33.14%228.63M
33.14%228.63M
33.14%228.63M
Retained profit
14.69%2.02B
18.89%1.93B
22.97%1.9B
25.41%1.78B
22.62%1.76B
20.82%1.63B
26.49%1.54B
26.66%1.42B
26.46%1.44B
39.15%1.35B
Less:Treasury stock
2,129.99%24.95M
-48.64%574.62K
-48.64%574.62K
-40.00%1.12M
-40.00%1.12M
-40.00%1.12M
--1.12M
--1.86M
--1.86M
--1.86M
Other composite income
--28.66M
--25.33M
----
----
----
----
----
----
----
----
Shareholders equity without minority interests
7.41%3.9B
9.69%3.84B
12.00%3.77B
12.98%3.65B
11.97%3.63B
10.89%3.5B
13.54%3.36B
12.89%3.23B
12.75%3.24B
16.43%3.15B
Minority interests
-4.40%1.88M
-1.88%2.03M
-19.21%1.82M
-19.89%1.88M
297.69%1.96M
370.48%2.07M
314.01%2.25M
--2.35M
--493.83K
--439.78K
Total shareholder equity
7.41%3.9B
9.68%3.84B
11.98%3.77B
12.96%3.65B
12.01%3.63B
10.94%3.5B
13.59%3.36B
12.97%3.23B
12.76%3.24B
16.44%3.15B
Total liabilityies and equity
-1.15%4.62B
6.39%4.67B
15.21%4.74B
17.22%4.53B
22.48%4.67B
17.86%4.39B
12.90%4.11B
16.21%3.87B
13.54%3.81B
19.75%3.73B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
--
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
--
--
--
Huaxing Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 10.24%800.29M27.56%581.74M49.61%692.16M-31.79%418.82M32.74%725.98M-17.88%456.07M-77.13%462.63M-67.69%614M-74.30%546.91M-70.98%555.36M
Transactional financial assets 13.03%695.12M10.40%745.04M69.15%910.04M188.48%793.04M153.12%614.96M216.90%674.83M156.20%538.01M30.91%274.9M51.84%242.95M-21.13%212.95M
Notes receivable and accounts receivable -24.10%312.35M-18.45%331.41M-5.23%395.76M16.90%414.46M46.90%411.54M47.62%406.38M85.23%417.61M86.60%354.54M23.67%280.14M48.88%275.29M
-Notes receivable -------------58.43%43.37M448.59%70.31M1,005.53%82.67M211.88%105.47M1,400.67%104.32M-18.38%12.82M-76.64%7.48M
-Accounts receivable -8.46%312.35M2.38%331.41M26.79%395.76M48.31%371.1M27.64%341.23M20.87%323.71M62.88%312.14M36.70%250.22M26.80%267.33M75.17%267.81M
Other receivables (including interest and dividends) -6.99%3.89M42.19%3.73M52.92%3.41M-17.28%4.18M-5.31%4.18M1.50%2.62M-33.01%2.23M46.92%5.05M74.61%4.42M16.57%2.58M
-Other receivable ----42.19%3.73M-----17.28%4.18M----1.50%2.62M----46.92%5.05M----16.57%2.58M
Advance payment -65.83%3.69M-15.72%7.69M-43.36%6.99M5.68%10M2.18%10.8M-11.30%9.12M-69.20%12.35M-59.67%9.46M-59.22%10.57M-47.12%10.29M
Inventories -15.70%146.44M-14.52%144.8M17.09%156.31M35.99%163.4M47.86%173.71M55.68%169.4M16.02%133.49M14.12%120.16M26.85%117.49M53.12%108.82M
Receivable financing -100.00%108,256.80%11.74M---------82.23%2.84M-99.27%140.44K--2M--2.02M--15.96M--19.11M
Non-current assets due within one year -42.74%484.15M-44.35%468.74M162.06%808.71M1,256.01%990.17M47.32%845.47M46.04%842.33M--308.59M--73.02M--573.9M--576.78M
Other current assets --26.85M--271.2M------------------------------129.84K
Total current assets -11.35%2.47B0.20%2.57B58.42%2.97B92.28%2.79B55.63%2.79B45.40%2.56B-28.30%1.88B-40.26%1.45B-31.99%1.79B-28.45%1.76B
Non Current assets
Other equity investment 49,846.86%99.89M48,185.89%96.57M33.33%200K33.33%200K33.33%200K33.33%200K0.00%150K50.00%150K50.00%150K50.00%150K
Fixed assets -----9.27%799.01M----8.10%839.29M----70.85%880.59M----48.49%776.4M----152.95%515.43M
Constru in process ----153.25%43.05M-----93.89%9.41M-----95.63%17M-----25.25%154.14M----9.79%388.72M
Productive biological assets --8.77M--10.05M--8.99M----------------------------
Intangible assets -0.76%58.52M0.19%60.03M4.16%58.87M0.96%58.03M2.64%58.97M4.67%59.91M0.18%56.52M3.06%57.47M8.77%57.45M7.16%57.24M
Goodwill 0.00%3.31M0.00%3.31M0.00%3.31M0.00%3.31M--3.31M--3.31M--3.31M--3.31M--------
Long deferred expense --1.11M--1.18M--------------------------------
Deferred tax assets -98.25%505.2K-98.88%299.89K51.21%34.86M64.13%31.87M61.16%28.9M64.69%26.8M15.98%23.06M18.65%19.42M39.03%17.94M42.06%16.28M
Usufruct assets -11.91%6.61M-12.82%6.79M6.20%6.92M7.30%7.21M--7.5M--7.79M--6.51M--6.72M--------
Other non current assets 24.95%1.14B30.06%1.08B-33.97%811.77M-43.51%788.13M-12.86%910.66M-15.42%834.13M1,867.06%1.23B1,403.47%1.4B904.86%1.05B3,619.43%986.2M
Total non current assets 13.96%2.15B15.05%2.11B-21.07%1.76B-27.99%1.74B-6.90%1.88B-6.84%1.83B118.19%2.24B169.84%2.41B179.11%2.02B202.47%1.96B
Total assets -1.15%4.62B6.39%4.67B15.21%4.74B17.22%4.53B22.48%4.67B17.86%4.39B12.90%4.11B16.21%3.87B13.54%3.81B19.75%3.73B
Liabilities
Current liabilities
Short term loan -37.52%155.08M57.02%206.65M225.67%228.16M693.18%238.15M2,378.61%248.19M629.98%131.6M45.74%70.06M-25.02%30.03M-66.66%10.01M-69.98%18.03M
Notes payable and accounts payable -45.80%120.83M-32.44%165.03M-29.47%180.04M-22.58%188.58M1.15%222.92M13.22%244.27M13.44%255.27M49.09%243.59M107.73%220.38M48.28%215.74M
-Notes payable -59.83%17.06M-31.88%32.69M17.03%40.24M-45.05%22.01M85.22%42.47M142.93%47.99M89.88%34.39M653.76%40.05M52.47%22.93M--19.76M
-Accounts payable -42.50%103.76M-32.58%132.34M-36.71%139.79M-18.16%166.57M-8.61%180.44M0.15%196.27M6.75%220.89M28.76%203.54M116.86%197.45M34.71%195.99M
Contract liabilities 5.24%203.85M54.97%157.61M31.96%207.22M63.25%137.02M37.85%193.69M60.96%101.7M-21.95%157.03M-23.52%83.93M-32.67%140.51M-1.23%63.18M
Salaries payable -18.24%20.59M0.33%49.57M29.10%43.9M10.68%32.44M53.28%25.18M0.73%49.41M-26.00%34M-28.49%29.31M-41.64%16.43M28.30%49.05M
Taxs payable 184.43%63.18M57.14%57.82M88.56%46.71M346.79%28.48M14.24%22.21M-31.64%36.79M-43.78%24.77M-43.99%6.38M-42.97%19.44M98.87%53.82M
Other payable (including interest and dividends) -24.36%40.3M-32.67%39.64M41.06%55.62M30.96%48.84M93.65%53.28M87.46%58.87M69.69%39.43M118.50%37.29M27.35%27.51M67.07%31.4M
-Other payable -----32.67%39.64M----30.96%48.84M----87.46%58.87M----118.50%37.29M----67.07%31.4M
Non current liabilities due within one year 2,996.75%31.18M12,416.81%81.11M39,602.61%81.08M81,425.93%51.04M-97.49%1.01M-98.92%648.04K--204.21K--62.61K--40.04M--60.06M
Other current liabilities -24.27%2.31M49.10%831.75K-94.79%2.99M-99.27%728.85K-22.99%3.06M-41.78%557.84K1,511.82%57.33M6,690.55%100.47M-15.91%3.97M67.68%958.19K
Total current liabilities -17.18%637.31M21.55%758.25M32.53%845.71M36.57%725.28M60.89%769.54M26.73%623.84M7.95%638.11M38.26%531.06M10.36%478.3M38.98%492.24M
Current liabilities
Estimate liabilities ------------0.00%1.99M0.00%1.99M0.00%1.99M-29.28%1.99M-29.28%1.99M-29.28%1.99M-29.28%1.99M
Deferred tax liabilities -74.23%15.01M-77.18%12.97M20.27%58M46.61%59.53M76.46%58.25M91.55%56.84M435.82%48.22M28.63%40.6M242.69%33.01M241.31%29.68M
Long term deferred income -7.32%56.71M-8.26%56.62M13.75%60M7.54%58.8M8.07%61.19M29.94%61.72M11.08%52.74M12.95%54.68M55.04%56.62M29.37%47.5M
Lease liabilities -15.44%5.67M-19.32%5.75M-2.71%6.43M-2.28%6.5M--6.71M--7.12M--6.61M--6.65M--------
Total non current liabilities -71.15%77.4M-71.87%75.34M13.56%124.42M50.90%156.82M192.78%268.25M238.25%267.79M22.70%109.57M25.53%103.92M87.11%91.62M64.16%79.17M
Total liabilities -31.13%714.71M-6.51%833.59M29.75%970.13M38.92%882.11M82.09%1.04B56.04%891.63M9.89%747.68M36.01%634.98M18.16%569.93M42.00%571.41M
Shareholders equity
Paid-in capital -0.01%466.17M-0.01%466.17M0.12%466.17M0.23%466.21M0.23%466.21M0.23%466.21M0.10%465.59M0.03%465.13M0.03%465.13M0.03%465.13M
Capital reserve funds 0.48%1.14B0.48%1.14B0.65%1.13B1.45%1.14B1.84%1.14B1.84%1.14B1.96%1.13B1.37%1.12B0.98%1.11B0.98%1.11B
Surplus reserve funds 0.00%269.37M0.00%269.37M17.82%269.37M17.82%269.37M17.82%269.37M17.82%269.37M33.14%228.63M33.14%228.63M33.14%228.63M33.14%228.63M
Retained profit 14.69%2.02B18.89%1.93B22.97%1.9B25.41%1.78B22.62%1.76B20.82%1.63B26.49%1.54B26.66%1.42B26.46%1.44B39.15%1.35B
Less:Treasury stock 2,129.99%24.95M-48.64%574.62K-48.64%574.62K-40.00%1.12M-40.00%1.12M-40.00%1.12M--1.12M--1.86M--1.86M--1.86M
Other composite income --28.66M--25.33M--------------------------------
Shareholders equity without minority interests 7.41%3.9B9.69%3.84B12.00%3.77B12.98%3.65B11.97%3.63B10.89%3.5B13.54%3.36B12.89%3.23B12.75%3.24B16.43%3.15B
Minority interests -4.40%1.88M-1.88%2.03M-19.21%1.82M-19.89%1.88M297.69%1.96M370.48%2.07M314.01%2.25M--2.35M--493.83K--439.78K
Total shareholder equity 7.41%3.9B9.68%3.84B11.98%3.77B12.96%3.65B12.01%3.63B10.94%3.5B13.59%3.36B12.97%3.23B12.76%3.24B16.44%3.15B
Total liabilityies and equity -1.15%4.62B6.39%4.67B15.21%4.74B17.22%4.53B22.48%4.67B17.86%4.39B12.90%4.11B16.21%3.87B13.54%3.81B19.75%3.73B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----------Unqualified opinion--------
Auditor ----------Huaxing Certified Public Accountants (Special General Partnership)------Huaxing Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg